Skip to content

Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00927420
Enrollment
300
Registered
2009-06-25
Start date
2009-07-31
Completion date
2009-10-31
Last updated
2009-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

Bipolar disorder, adherence, treatment, real life practice

Brief summary

The purpose of this study is to estimate adherence to treatment in bipolar patients, to characterize patients based on adherence degree and to describe the variables linked to poor adherence to treatment in real-life practice.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with bipolar disorder I or II DSM-IV * Patients treated with at least one oral antipsychotic * Subjects able to read and write

Exclusion criteria

* Patients participating in clinical trials

Design outcomes

Primary

MeasureTime frame
Morisky-Green ScaleOnce, at the visit moment
Drug Attitude Inventory Scale (DAI-10)Once, at the visit moment

Secondary

MeasureTime frame
Clinical Global Impressions for Bipolar illness-modified (CGI-BP-M)Once, at the visit moment
Functioning Assessment Short Test (FAST)Once, at the visit moment

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026